The effect of statins on serum prostate specific antigen levels in a cohort of airline pilots: A preliminary report

Journal of Urology

Volumn 173, Issue 6, 2005, Pages 1923-1925

  Cyrus David, Mfon S ^a   Weinberg, Armin ^a   Thompson, Timothy ^a   Kadmon, Dov ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cholesterol; Hydroxymethylglutaryl CoA reductase inhibitors; Prostate; Prostate specific antigen

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; PROSTATE SPECIFIC ANTIGEN; STATINE DERIVATIVE;

ADULT; AIRPLANE PILOT; CANCER RISK; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; MALE; MEDICAL RECORD; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; REVIEW; STATISTICAL SIGNIFICANCE; VALIDATION PROCESS; WILCOXON SIGNED RANKS TEST;

EID: 18744387733     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000158044.94188.88     Document Type: Article

References (20)

1. Blais, L., Desgagne, A. and LeLorier, J.: 3-Hydroxy 3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer: a nested case-control study. Arch Intern Med, 160: 2363, 2000
2. Coogan, P. F., Rosenberg, L., Palmer, J. R., Strom, B. L., Zauber, A. G. and Shapiro, S.: Statin use and risk of breast and prostate cancer. Epidemiology, 13: 262, 2002
3. Stark, W. W., Jr., Blaskovich, M. A., Johnson, B. A., Qian, Y., Vasudevan, A., Pitt, B. et al: Inhibiting geranylgeranylation blocks growth and promotes apoptosis in pulmonary vascular smooth muscle cells. Am J Physiol, 275: L55, 1998
4. Buemi, M., Allegra, A., Senatore, M., Marino, D., Medici, M. A., Aloisi, C. et al: Pro-apoptotic effect of fluvastatin on human smooth muscle cells. Eur J Pharm, 370: 201, 1999
5. Ukomadu, C. and Dutta, A.: Inhibition of cdk2 activating phosphorylation by mevastatin. J Biol Chem, 278: 4840, 2003
6. Shibata, M. A., Kavanaugh, C., Shibata, E., Abe, H., Nguyen, P., Otsuki, Y. et al: Comparative effects of lovastatin on mammary and prostate oncogenesis in transgenic mouse models. Carcinogenesis, 24: 453, 2003
7. Park, C., Lee, I. and Rang, W. K.: Lovastatin-induced E2F-1 modulation and its effect on prostate cancer cell death. Carcinogenesis, 22: 1727, 2001
8. Ukomadu, C. and Dutta, A.: p21-Dependent inhibition of colon cancer cell growth by mevastatin is independent of inhibition of G1 cyclin-dependent kinases. J Biol Chem, 278: 43586, 2003
9. Newton, C. J., Ran, G., Xie, Y. X., Bilko, D., Burgoyne, C. H., Adams, I. et al: Statin-induced apoptosis of vascular endothelial cells is blocked by dexamethasone. J Endocrinol, 174: 7, 2002
10. Edwards, P. A. and Ericsson, J.: Sterols and isoprenoids: signaling molecules derived from the cholesterol biosynthetic pathway. Annu Rev Biochem, 68: 157, 1999
11. Sinensky, M.: Recent advances in the study of prenylated proteins. Biochim Biophys Acta, 1484: 93, 2000
12. Perez-Sala, D. and Mollinedo, F.: Inhibition of isoprenoid biosynthesis induces apoptosis in human promylocytic HL-60 cells. Biochem Biophys Res Commun, 199: 1209, 1994
13. Denoyelle, C., Vasse, M., Korner, M., Mishal, Z., Ganne, F., Vannier, J. P. et al: Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: an in vitro study. Carcinogenesis, 22: 1139, 2001
14. Ginsberg, H. N. and Goldberg, I. J.: Disorders of lipoprotein metabolism. In: Harrison's Principles of Internal Medicine, 15th ed. Edited by E. Braunwald, A. S. Fauci, D. L. Kasper, S. L. Hauser, D. L. Longo and J. L. Jameson. New York: McGraw-Hill Medical Publishing Division, chapt. 344, pp. 2245-2257, 2001
15. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA, 269: 3015, 1993
16. Walker, G. A.: Common Statistical Method for Clinical Research With SAS Examples. Cary, North Carolina: SAS Publishing, chapt. 13, pp. 237-245, 2002
17. Holund, B.: Latent prostate cancer in conservative autopsy series. Scand J Urol Nephrol, 14: 29, 1980
18. Eastham, J. A., Riedel, E., Latkany, L., Fleisher, M., Schatzkin, A., Lanza, E. et al: Dietary manipulation, ethnicity and serum PSA levels. Urology, 62: 677, 2003
19. Moyad, M. A. and Sonnleithner, M.: Prostate cancer and coronary heart disease: correlation or coincidence? Urol Clin North Am, 31: 207, 2004
20. Graaf, M. R., Beiderbeck, A. B., Egberts, A.C., Richel, D. J. and Guchelaar, H. J.: The risk of cancer in users of statins. J Clin Oncol, 22: 2388, 2004